Abstract
Oral rehabilitation is a major issue in patients with severe oncological diseases or osteoporosis in order to ensure a better quality of life. Whenever possible, oral rehabilitation should be considered. However, new prostheses and sore spots are often underestimated in regard to their risk of triggering medication-related osteonecrosis of the jaw (MRONJ) lesions. Dental care with monitoring oral hygiene and preserving teeth is essential in MRONJ prophylaxis. Prosthetic treatment should avoid the need of invasive dentoalveolar procedures during antiresorptive therapy if possible because these situations are associated with a risk to trigger MRONJ onset. Clinicians and patients should be aware of these risks. Planning of prostheses and continuous recalls adapted to the individual risk of MRONJ will reduce the patients’ risk considerably. The chapter describes the planning of prosthetic oral rehabilitation of patients receiving oral and intravenous bisphosphonate administrations as well as rehabilitation of patients with a history of MRONJ.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Waller A, Groff SL, Hagen N, Bultz BD, Carlson LE. Characterizing distress, the 6th vital sign, in oncology pain clinic. Curr Oncol. 2012;19(2):e53–9.
Ringe JD. Therapie chronischer Schmerzen des Bewegungsapparates mit Opioiden. J Mineralsoffw. 2002;9:23–5.
Fueki K, Yoshida E, Igarashi Y. A structural equation model relating objective and subjective masticatory function and oral health-related quality of life in patients with removable partial dentures. J Oral Rehabil. 2011;38(11):810–7.
Veyrune JL, Tubert-Jeannin S, Dutheil C, Riordan PJ. Impact of new prostheses on the oral health related quality of life of edentulous patients. Gerodontology. 2005;22(1):3–9.
Hantsch ROA, Al-Omiri MK, Yunis MA, Dar-Odeh N, Lynch E. Relationship between impacts of complete denture treatment on daily living, satisfaction and personality profiles. J Contemp Dent Pract. 2011;12(3):200–7.
Fehm T, Felsenberg D, Krimmel M, Solomayer E, Wallwiener D, Hadjii P. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Breast. 2009;18(4):213–7.
Özhayat EB, Gotfredsen K. Effect of treatment with fixed and removable dental prostheses. An oral health-related quality of life study. J Oral Rehabil. 2012;39(1):28–36.
AWMF-Register Nr. 007/091. Bisphosphonat-assoziierte Kiefernekrosen (BP-ONJ) und andere Medikamenten-assoziierte Kiefernekrosen. 2012. http://www.awmf.org/uploads/tx_szleitlinien/007-091l_S3_Bisphosphonat-assoziierte_Kiefernekrose_2012-04.pdf (Stand 3/2014).
Ruggiero SL, Didson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67 Suppl 1:2–12.
Gallego L, Junquera L, Pelaz A, Diaz-Bobes C. Rubber dam clamp trauma during endodontic treatment: a risk factor of bisphosphonate-related osteonecrosis of the jaw? J Oral Maxillofac Surg. 2011;69:e93–5.
Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol. 2009;27(32):5356–62.
Kyrigidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas J, Teleioudis Z, Patrikidou A, Triaridis S. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol. 2008;26(6):4634–8.
Vescovi P, Campisi G, Fusco V, Mergoni G, Manfredi M, Merigo E, Solazzo L, Gabriele M, Gaeta GM, Favia G, Peluso F, Coltella G. Surgery-triggered and non surgery- triggered bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol. 2011;47(3):191–4.
Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel R, Hortobagyi GH. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res. 2008;23(6):826–36.
Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int. 2007;18(10):1363–70.
Levin L, Laviv A, Schwarts-Arad D. Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment. J Am Dent Assoc. 2007;138(8):1218–20.
Hoefert S. Prothesendruckstellen als Risiko einer Bisphosphonat-assoziierten Kiefernekrose. ZWR. 2012;121(11):564–71.
Hasegawa Y, Kawabe M, Kimura H, Kurita K, Kukuta J, Urade M. Influence of dentures in the initial occurrence site on the prognosis of bisphosphonate-related osteonecrosis of the jaw: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(3):318–24.
Ravosa MJ, Ning J, Liu Y, Stack MS. Bisphosphonates effects on the behaviour of oral epithelial cells and oral fibroblasts. Arch Oral Biol. 2011;56(5):491–8.
Pabst AM, Ziebart T, Koch FP, Taylor KY, Al-Nawas B, Walter C. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes – in vitro study. Clin Oral Investig. 2012;16(1):87–93.
Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Schuler CF, Costerton JW. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonates therapy. J Oral Maxillofac Surg. 2008;66(4):767–75.
Kivovics P, Jahn M, Borbely J, Marton K. Frequency and location of traumatic ulcerations following placement of complete dentures. Int J Prosthodont. 2007;20(4):397–401.
Ruggiero SL. An office-based approach to the diagnosis and management on osteonecrosis. Atlas Oral Maxillofac Surg Clin North Am. 2013;21(2):167–73.
Tripathi A, Pandey S, Singh SV, Sharma NK, Singh R. Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns. J Prosthodont. 2011;20(7):601–3.
Garret NR, Kapur KK, Perez P. Effects of improvements of poorly fitting dentures and new dentures on patients satisfaction. J Prosthet Dent. 1996;76(10):403–13.
Göllner M, Holst S, Fenner M, Schmitt J. Prosthodontic treatment of a patient with bisphosphonate-induced osteonecrosis of the jaw using a removable dental prosthesis with a heat-polymerized resilient liner: a clinical report. J Prosthet Dent. 2010;103(4):196–201.
Kawano F, Tada N, Nagao K, Matsumoto N. The influence of soft lining materials on pressure distribution. J Prosthet Dent. 1991;6(4):567–75.
Maruta H, Haberham RC, Hamada T, Taguchi N. Settings and stress relaxation behaviour of resilient denture liners. J Prosthet Dent. 1998;80(6):714–22.
Taguchi N, Murata H, Hamada T, Hong G. Effect of viscoelastic properties of resilient venture liners on pressures under dentures. J Oral Rehabil. 2001;28(11):1003–8.
Wagner WC, Kawano F, Dootz ER, Koran A. Dynamic viscoelastic properties of processed soft denture liners: part II-effect of aging. J Prosthet Dent. 1995;74(3):299–304.
Okita N, Orstavik D, Ostavik J, Ostby K. In vivo and in vitro studies on soft denture materials: microbial adhesion and tests for antibacterial activity. Dent Mater. 1991;7:155–60.
Döring K, Linek W, Spieckermann J. Die Bisphosphonat-assoziierte Kiefernekrose. Oralchirurgie J. 2007;1:26–30.
Felton D, Cooper L, Duqum I, Minsley G, Guckes A, Haug S, Meredith P, Solie C, Avery D, Chandler ND. Evidence-based guidelines for the care and maintenance of complete dentures: a publication of the American College of Prosthodontics. J Prosthodont. 2011;20 Suppl 1:S1–12.
Stark H, Wolowski A, Ehmke B. Nachsorgestrategien für Zahnersatz. ZM. 2011;101(8):60–4.
Depprich R, Naujoks C, Lind D, Ommerborn M, Meyer U, Kübler J, Hendschel J. Evaluation of the quality of life of patients with maxillofacial defects after prosthodontic therapy with obturator prostheses. Int J Oral Maxillofac Surg. 2011;40(1):71–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hoefert, S., Sharghi, F., Engel, E. (2015). Dental Rehabilitation in Patients Receiving Antiresorptive Drugs. In: Otto, S. (eds) Medication-Related Osteonecrosis of the Jaws. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43733-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-662-43733-9_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43732-2
Online ISBN: 978-3-662-43733-9
eBook Packages: MedicineMedicine (R0)